Antibodies targeting talaromyces marneffei mp1p protein and methods of use thereof
US-2024199726-A1 · Jun 20, 2024 · US
Pneumococcal serotypes
US9778266B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9778266-B2 |
| Application number | US-201313890864-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 9, 2013 |
| Priority date | Dec 28, 2005 |
| Publication date | Oct 3, 2017 |
| Grant date | Oct 3, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed is a new and emerging serotype of Streptococcus pneumoniae designated serotype 6C, and assays and monoclonal antibodies useful in identifying same. Also disclosed is a novel pneumococcal polysaccharide with the repeating unit {2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→3) ribitol (5→phosphate}. This new serotype may be included in pneumococcal vaccines.
First claim
Opening claim text (preview).
The invention claimed is: 1. An assay component comprising an isolated antigen binding molecule that binds specifically to a polysaccharide repeating unit: {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→3) ribitol (5→phosphate}. 2. An assay component comprising an isolated antigen binding molecule that binds with specificity to an antigen consisting of a polysaccharide repeating unit {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→3) ribitol (5→phosphate}. 3. The assay component of claim 1 , wherein the isolated antigen binding molecule is a recombinant antigen binding molecule, a synthetic antigen binding molecule, a monoclonal antibody, or a polyclonal antibody. 4. An assay component that binds specifically to a polysaccharide having the repeating unit: {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→3) ribitol (5→phosphate}, wherein the component comprises a monoclonal antibody is able to opsonize pneumococcal serotype designate 6C. 5. The assay component of claim 1 or 2 , wherein said antigen binding molecule is bound to an artificial solid surface.
Assignees
Inventors
Classifications
Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof · CPC title
Streptococcus (G) · CPC title
Streptococcus · CPC title
Streptococcus; Staphylococcus · CPC title
Streptococcus · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9778266B2 cover?
- Disclosed is a new and emerging serotype of Streptococcus pneumoniae designated serotype 6C, and assays and monoclonal antibodies useful in identifying same. Also disclosed is a novel pneumococcal polysaccharide with the repeating unit {2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→3) ribitol (5→phosphate}. This new serotype may be included in pneumococcal vaccines.
- Who is the assignee on this patent?
- The Uab Found, Fundacao Oswaldo Cruz, Inst Adolfo Lutz, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification G01N33/6854. Mapped technology areas include Physics.
- When was this patent published?
- Publication date Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).